A criticism of healthy-years equivalents
Related Experiment Video
Updated: Nov 4, 2026

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans
Published on: May 18, 2022
1Medical Decision Making Unit, University of Leiden, The Netherlands.
Abstract:
The following questions describe the scope of this paper. When decision trees are used to analyze optimal decisions, should end nodes be evaluated on the basis of QALYs or on the basis of healthy-years equivalents? Which measures should be used in communications with others, e.g., patients? Which of these measures incorporate risk attitudes, and which do not? It is demonstrated that the healthy-years equivalent measure does not stand scrunity.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Energy Budgets and Reproductive Strategies
The Effect of Aging on Tissues
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Regression Toward the Mean
